Arkolith/Insider Trading/ALDX/Form 4

Machatha Stephen

Chief Development OfficerAldeyra Therapeutics, Inc. (ALDX) · full profile →Form 4 · filed Aug 13, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$114K
Net Open-Market Flow
-$114K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2025Sell(S)22K$5.15$114K222K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-108210) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML